Skip to main content
Log in

Pulmonary resection for nontuberculous mycobacterial pulmonary disease: outcomes and risk factors for recurrence

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

As the number of patients with nontuberculous mycobacterial pulmonary disease (NTMPD) increases, surgical treatment to control disease becomes more important. However, postoperative outcomes and predictors of recurrence have been insufficiently evaluated.

Methods

We retrospectively investigated 100 patients with NTMPD who underwent pulmonary resection from 2009 to 2016 at our institution. Clinical data of patients with and without postoperative recurrence were statistically compared. Recurrence was defined as microbiological re-identification or computed tomography findings highly suspicious for relapse after excluding other diseases. Recurrence-free survival was calculated using the Kaplan–Meier method. Survival curves were compared using the log-rank test. Predictive factors were evaluated using univariate and multivariate analyses.

Results

Nine patients experienced recurrence. A significant difference in recurrence-free survival was detected between patients with and without a positive preoperative sputum culture (P = 0.000942). Moreover, patients with a positive preoperative sputum smear (≥ 2 +) had a significantly higher recurrence rate than those who did not (P = 0.000216). Multivariate analysis revealed that preoperative sputum smear (≥ 2 +) is an independent risk factor for recurrence after pulmonary resection for NTMPD (odds ratio, 7.38; 95% confidential interval, 1.29–42.2; P = 0.024).

Conclusions

NTM discharge might have an impact on postoperative recurrence of NTMPD patients without residual cavitary lesions. Preoperative NTM discharge should be minimized by optimizing medical therapy before surgical treatment to improve the postoperative course. Intensive follow-up and prolonged postoperative medical therapy should be considered for patients without a sufficient reduction in bacterial discharge before pulmonary resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adjemian J, Oliver KN, Seitzs AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit are Med. 2012;185:881–6.

    Article  Google Scholar 

  2. Henry MT, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J. 2004;23:741–6.

    Article  CAS  Google Scholar 

  3. Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J. 2006;28:1211–5.

    Article  CAS  Google Scholar 

  4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatmet and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.

    Article  CAS  Google Scholar 

  5. Weber A, Stammberger U, Inci I, Schmid RA, Dutly A, Weder W. Thoracoscopic lobectomy for benign disease-a single centre study on 64 cases. Eur J Cardiothorac Surg. 2001;20:443–8.

    Article  CAS  Google Scholar 

  6. Zhang P, Zhang F, Jiang S, Jiang G, Zhou X, Ding J, et al. Video-assisted thoracic surgery for bronchiectasis. Ann Thorac Surg. 2011;91:239–43.

    Article  Google Scholar 

  7. Sakane T, Matsuoka K, Kumata S, Watanabe R, Yamada T, Matsuoka T, et al. The outcomes of anatomical lung resection for nontuberculous mycobacterial lung disease. J Thorac Dis. 2018;10:954–62.

    Article  Google Scholar 

  8. Chang KC, Leung CC, Yew WW, et al. A nested case control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004;170:1124–30.

    Article  Google Scholar 

  9. Chang KC, Leung CC, Yew WW, Chan SL, Tam CM. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med. 2006;174:1153–8.

    Article  Google Scholar 

  10. Jo KW, Yoo JW, Hong Y, Lee JS, Lee SD, Kim WS, et al. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med. 2014;108:654–9.

    Article  Google Scholar 

  11. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 1999;2000(161):1376–95.

    Google Scholar 

  12. Shiraishi Y, Katsuragi N, Kita H, Hyogotani A, Saito MH, Shimoda K. Adjuvant surgical treatment of nontuberculous mycobacterial lung disease. Ann Thorac Surg. 2013;96:287–92.

    Article  Google Scholar 

  13. Wallace RJ Jr, Brown-Elliot BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Marcrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146:276–82.

    Article  CAS  Google Scholar 

  14. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011;52:565–71.

    Article  Google Scholar 

  15. Van Lngen J, Verhagen AF, Dekhuijzen PN, van Soolingen D, Magis-Escurra C, Boeree MJ, et al. Surgical treatment of non-tuberculus nycobacterial lung disease: strike in time. Int J Tuberc Lung Dis. 2010;14:99–105.

    Google Scholar 

  16. Mitchell JD, Yu JA, Bishop A, Weyant MJ, Pomerantz M. Thoracoscopic lobectomy and segmentectomy for infectious lung disease. Ann Thorac Surg. 2012;93:1033–40.

    Article  Google Scholar 

  17. Koh WJ, Kim YH, Kwon OJ, Choi YS, Kim K, Shim YM, et al. Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci. 2008;23:397–401.

    Article  Google Scholar 

  18. Yu JA, Pomerantz M, Bishop A, Weyant MJ, Mitchell JD. Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease. Eur J Cardiothorac Surg. 2011;40:671–5.

    Article  Google Scholar 

  19. Yamada K, Seki Y, Nakagawa T, Hayashi Y, Yagi M, Ogawa K. Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease. Gen Thorac Cardiovasc Surg. 2019;67:363–9.

    Article  Google Scholar 

  20. Asakura T, Hayakawa N, Hasegawa N, Namkoong H, Takeuchi K, Suzuki S, et al. Long-term outcome of pulmonary resection for nontuberculous mycobacterial pulmonary disease. Clin Infect Dis. 2017;65:244–51.

    Article  Google Scholar 

  21. Canetti G. Present aspect of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965;92:687–703.

    CAS  PubMed  Google Scholar 

  22. Palaci M, Dietze R, Hadad DJ. Cavitary disease and quantitative sputum bacillary load in case of pulmonary tuberculosis. J Clin Microbiol. 2007;45:4064–6.

    Article  Google Scholar 

  23. Lee BY, Kim S, Hong Y, Lee SD, Kim WS, Kim DS, et al. Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease. Antimicrob Agents Chemother. 2015;5:2972–7.

    Article  Google Scholar 

  24. Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest. 2014;146:276–82.

    Article  CAS  Google Scholar 

  25. Colombo RE, Hill SC, Claypool RJ, Holland SM, Olivier KN. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest. 2010;137:629–34.

    Article  Google Scholar 

  26. Yamada K, Yasuda A, Seki Y, Fukui Y, Yagi M, Tarumi O, et al. Risk factors for recurrence after surgical treatment of nontuberculous mycobacterial lung disease. Kekkaku. 2017;92:451–7.

    Google Scholar 

  27. Han D, Lee KS, Yi CA, Kim TS, Kwon OJ. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobactrium abscessus. AJR Am J Roentqenol. 2003;181:513–7.

    Article  Google Scholar 

Download references

Funding

There was no funding from any organizations or companies. Notation of prior abstract publication/presentation: None.

Author information

Authors and Affiliations

Authors

Contributions

Yotsumoto T contributed to data collection, data analysis, and wrote the initial draft of the manuscript. Inoue Y and Fukami T designed the study, contributed to data analysis and interpretation, and assisted in the preparation of the manuscript.

Corresponding author

Correspondence to Takuma Yotsumoto.

Ethics declarations

Conflict of interest

None declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yotsumoto, T., Inoue, Y., Fukami, T. et al. Pulmonary resection for nontuberculous mycobacterial pulmonary disease: outcomes and risk factors for recurrence. Gen Thorac Cardiovasc Surg 68, 993–1002 (2020). https://doi.org/10.1007/s11748-020-01326-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-020-01326-1

Keywords

Navigation